Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Bellicum Pharmaceuticals Inc. (BLCM)

0.8835   -0.081 (-8.45%) 11-11 16:00
Open: 0.96 Pre. Close: 0.965
High: 0.96 Low: 0.87
Volume: 522,783 Market Cap: 44M
Bellicum Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The firm is primarily engaged in the research of cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.962 - 0.967 0.967 - 0.971
Low: 0.858 - 0.864 0.864 - 0.869
Close: 0.872 - 0.881 0.881 - 0.888

Technical analysis

as of: 2019-11-11 4:30:31 PM
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.38     One year: 1.72
Support: Support1: 0.72    Support2: 0.60
Resistance: Resistance1: 1.18    Resistance2: 1.47
Pivot: 0.96
Moving Average: MA(5): 1.05     MA(20): 0.92
MA(100): 1.23     MA(250): 2.44
MACD: MACD(12,26): 0.02     Signal(9): 0.01
Stochastic oscillator: %K(14,3): 26.72     %D(3): 42.42
RSI: RSI(14): 46.03
52-week: High: 5.44  Low: 0.72  Change(%): -78.8
Average Vol(K): 3-Month: 86713  10-Days: 134662

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
BLCM has closed above bottom band by 39.2%. Bollinger Bands are 51.1% wider than normal. The large width of the bands suggest high volatility as compared to BLCM's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

Mon, 24 Dec 2018 15:08:00 +0000
Jazz (JAZZ) Falls as Sleep Drug Gets Extended Review From FDA

Tue, 11 Dec 2018 14:22:00 +0000
Novan Announces Top-Line Data From Mid-Stage Molluscum Study

Tue, 24 Apr 2018 15:00:00 +0000
Is Bellicum Pharmaceuticals, Inc. a Buy?

Thu, 12 Apr 2018 15:37:00 +0000
FDA Lifts Clinical Hold on Bellicum's (BLCM) T Cell Therapy

Thu, 12 Apr 2018 13:55:00 +0000
Company News For Apr 12, 2018

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 49.62
Shares Float (M) 38.69
% Held by Insiders 5.24
% Held by Institutions 53.79
Shares Short (K) 2090
Shares Short P. Month (K)

Stock Financials

EPS -2.447
Book Value (p.s.) 0.030
PEG Ratio
Profit Margin
Operating Margin -4307.97
Return on Assets (ttm) -45.0
Return on Equity (ttm) -192.1
Qtrly Rev. Growth -64.7
Gross Profit (p.s.) -1.420
Sales Per Share
EBITDA (p.s.) -1.870
Qtrly Earnings Growth
Operating Cash Flow (M) -85.24
Levered Free Cash Flow (M) 11.10

Stock Valuations

P/E -0.36
P/E Growth Ratio -0.08
P/BV 29.45
P/S 17.67
P/CF -0.51

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.